The escalation of tariffs initiated by Donald Trump is setting the stage for a dramatic shift in the global economy with the ...

Autoliv (NYSE:ALV) shares soar 9% after beating forecasts. Discover how cost-cutting, resilience, and strong Q1 profits drive ...

Olaparib, an inhibitor of poly (ADP-ribose) polymerase (PARP), has demonstrated promising outcomes in treating HER2-negative early-stage breast cancer with BRCA mutations. However, a comprehensive ...

In a statistical analysis, Brukinsa resulted in fewer cases of disease progression or death and resulted in lower overall healthcare costs than Imbruvica in patients with chronic lymphocytic leukemia.

Discover Movado Group's Q4 2025 earnings highlights: sales growth, profit margin gains, cost-saving strategies, and enhanced ethics.

The pricing structure for prescription drugs is confusing and frustrating for patients and the people who dispense them. Rep.

On this episode of HL Shorts we hear from James Dregney, CFO of Sauk Prairie Healthcare. Dregney dives into the opportunities and challenges that arise when implementing value-based care models, ...

Potential treatments need to be subject to the highest standards of safety and efficacy. Transplanting dopamine-releasing neurons into the brain is a promising regenerative therapy for Parkinson ...

We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not ...

The California Supreme Court has clarified how the cost-shifting provisions of California Code of Civil Procedure Section 998 (“Section 998”) ...

Back in 1934, Ralph Nelson Elliott discovered that price action displayed on charts, instead of behaving in a somewhat chaotic manner, had actually an intrinsic narrative attached. Elliot saw the ...